| Törnsén, Maria (Passage Bio 202107– Chief Commercial Officer before Sarepta Therapeutics + Sanofi Genzyme + Shire) |
Chief Commercial Officer (CCO) |
Passage Bio Inc. (PASG) |
United States (USA) |
| Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) |
Chief Operating Officer (COO) |
Danaher (Group) |
Germany |
| Udier-Blagovic, Marina (Nouscom 202002– CEO joined 201609 as COO before Versant Ventures + Novartis + McKinsey) |
Chief Operating Officer (COO) |
Nouscom (Group) |
Switzerland |
| Ueberschaar, Nico (Univ Jena 201806 Head of MS platform) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
| Uecke, Oliver (Lipotype GmbH 201410 Head Business Development + Finance) |
Business Development Manager / Strategy Manager |
Lipotype GmbH |
Germany |
| Ueda, Teruhisa (Shimadzu 201504– CEO before General Manager Analytical + Measuring Instruments division joined 1082) |
Chief Executive Officer (CEO) |
Shimadzu (Group) |
Japan |
| Ueffing, Marius (Helmholtz 201202 Head Research Unit Protein Science at Helmholtz-Zentrum München) |
Researcher (university / research institute) |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Uhl, Nikolaus (Weitnauer Rechtsanwälte 200809 Berlin) |
n. a. |
Weitnauer Partnerschaft mbB Rechtsanwälte Steuerberater |
Germany |
| Uhlmann, Karen (Omeicos Therapeutics GmbH 201312 Managing Director) |
Managing Director |
Omeicos (Group) |
Germany |
| Uhrich, Christian (Merck (DE) 202306 Principal at M Ventures) |
Principal (venture capital) |
Merck (DE) (Group) |
Netherlands |
| Ulbrich, Claudia (Cardior Therapeutics 201705– CEO before T-Cell Europe GmbH 201205 Managing Director) |
Managing Director |
Cardior Pharmaceuticals GmbH |
Germany |
| Ullerich, Lars (GNA Biosolutions GmbH 201507 Managing Director) |
Managing Director |
GNA Biosolutions GmbH |
Germany |
| Ullmann, Dirk (Evotec 202209 Global Head Drug Discovery Services before Proteros Biostructures + Evotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Germany |
| Ullrich, Axel (Max Planck 201102 Director MPI for Biochemistry, Dept. of Molecular Biology) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Ullrich, Dirk (Axicorp 201105 Managing Director) |
Managing Director |
Biocon (Group) |
Germany |
| Ullrich, Matthias (Jabocs Univ 201207 Prof of Microbiology at School of Engineering and Science) |
Professor |
Schaffhausen Institute of Technology (SIT) |
Germany |
| Ulmer, Thomas (Immatics 201804– CFO before Merck (DE) as CFO of Allergopharma business unit) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Germany |
| Ulmer-Eilfort, Constanze (PSP Peters, Schönberg & Partner 202303 Partner) |
Attorney / Lawyer |
PSP Peters, Schönberger & Partner |
|
| Ulmer-Weber, Manfred (SHS 202208– Managing Partner before Partner + Senior Investment Manager joined 2010) |
Managing Partner (investment firm) |
SHS Capital (Group) |
Germany |
| Ulsemer, Philippe R. R. (Acaryon GmbH 202001– Managing Director + Co-Founder) |
Managing Director |
Acaryon GmbH |
Germany |
| Ulshöfer, Veit (Merck (DE) 201507 Director + Global Head of Research + Bioinformatics) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Ulyanova, Elena (Entelechon 201208 Business Development + Marketing Manager at PolyQuant GmbH) |
Business Development Manager / Strategy Manager |
PolyQuant GmbH |
Germany |
| Umaña, Pablo (GlycaArt 200810 CSO and Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Roche (Group) |
Switzerland |
| Umbarger, Ken (Schauenburg 201509 VP Sales + Services Americas for Markes) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United States (USA) |
| Underwood, George (Huntsworth 202109 at Medistrava Consulting) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United Kingdom (GB) |
| Ungeheuer, Udo (Schott 200603) |
n. a. |
Schott (Group) |
Germany |
| Unger, Hermann (United Nations 201011 Project Manager for Joint FAO/IAEA Programme) |
n. a. |
UN (United Nations) |
Austria |
| Ungerer, Martin (Corimmun 2006 Co-founder before Procorde) |
Company Founder |
Johnson & Johnson (JnJ) (Group) |
Germany |
| Unkelbach, Gerd (Fraunhofer 201311 Head of CBP in Leuna) |
n. a. |
Fraunhofer (Group) |
Germany |
| Unterrainer, Gertraud (ProBioGen 200710– CFO before Biovertis) |
Chief Financial Officer (CFO) |
Minapharm (Group) |
Germany |
| Uppenkamp, Reinhard (Menarini 201611 CEO of Berlin-Chemie) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Germany |
| Urbas, Lidija (BIA Separations 201505 Marketing) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Austria |
| Urech, David (Numab 201910 CEO + Co-Founder before Esbatech 2004–2010) |
Chief Executive Officer (CEO) |
Numab (Group) |
Switzerland |
| Urrios, Arturo (Wellington Partners 202109 Senior Associate) |
Investment Manager |
Wellington Partners (Group) |
Germany |
| Uschmann, Katrin (Thüringen (govt) 201512 Investment Manager at bm|t) |
Investment Manager |
Thuringia (govt region) |
Germany |
| Usoskin, Alexander (Bruker 201006 R&D Manager HTS at BEST) |
Research & Development Manager |
Bruker (Group) |
United States (USA) |
| Ustav, Mart (Icosagen 202302 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Icosagen (Group) |
Estonia |
| Ustav, Mart, Jr. (Icosagen 202212 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Icosagen (Group) |
Estonia |
| Usui, Akira (Ray Life Sciences 2007– President + founder before Perlegen Japan + Roche Japan + Tanabe Seiyaku) |
President/Director/Head Business Group/Unit/Division |
Ray Life Sciences Inc. (RLS) |
Japan |
| Uteng, Marianne (Novartis 202010 Associate at Novartis Venture Fund) |
n. a. |
Novartis (Group) |
Switzerland |
| Uth, Christina (Sulfotools GmbH 201603– Managing Director + Co-Founder) |
Managing Director |
Sulfotools GmbH |
Germany |
| Utiger, Lukas (Lonza 201208 COO of Lonza Bioscience STEPPED DOWN 2/13) |
Chief Operating Officer (COO) |
Lonza (Group) |
Switzerland |
| Utku, Nalân (CellAct Pharma 200707– Managing Director + co-founder before GenPat77 200608 CEO) |
Managing Director |
CellAct Pharma GmbH |
Germany |
| Vachicouras, Nicolas (Neurosoft Bioelectronics 202103 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Neurosoft Bioelectronics (CH) |
Switzerland |
| Vafa, Omid (TeneoBio 201706 CBO) |
Chief Business Officer (CBO) |
Teneobio Inc. |
United States (USA) |
| Vahrson, Wolfgang (Genedata 200910 before Microdiscovery 200501) |
n. a. |
Genedata (Group) |
Switzerland |
| Valdenaire, Olivier (Mestex 2014– CEO) |
Chief Executive Officer (CEO) |
|
|
| Valdettaro, Sharon (Roche 201109 Roche Partnering) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
| Valdez, John (NanoTemper 202205 Director of Marketing) |
Sales Manager / Marketing Manager |
NanoTemper (Group) |
United States (USA) |
| Valente, Nancy (Immatics 202203– Non-executive Board Director formerly at Genentech/Roche) |
Board member, non-executive |
Immatics (Group) |
Netherlands |
| Valentiner, Mark (Boehringer 202304 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
| Valinder, Kerstin (Nycomed 200808 Executive VP Business Developm) |
Business Development Manager / Strategy Manager |
Takeda (Group) |
Switzerland |
| Valla, Svein (NTNT 2008 Professor) |
Professor |
NTNU (Norwegian University of Science and Technology) |
Norway |
| Valor, Santiago (Synlab 201603 CMO) |
Chief Medical Officer (CMO) |
Synlab (Group) |
Germany |
| Valtink, Peter (Gesundheitswirtschaft Nordwest 201105 Senior Project Manager) |
Business Development Manager / Strategy Manager |
Gesundheitswirtschaft Nordwest e. V. |
Germany |
| Van Acker, Bart (Quality by Design 202204 CEO + Founder) |
Chief Executive Officer (CEO) |
QbD Group (Quality by Design) (Group) |
Belgium |
| van Aken, Tom B. (Avantium 200602– CEO) |
Chief Executive Officer (CEO) |
Avantium (Group) |
Netherlands |
| van Alphen, Frits (Inositec 201801–CMO before Roche + Vifor Pharma + Novartis) |
Chief Medical Officer (CMO) |
Vifor Pharma (Group) |
Switzerland |
| Van Beneden, Patrick (GIMV 201306) |
Investment Manager |
Gimv (Group) |
Belgium |
| van Berkel, Patrick (Celtic Therapeutics 201207– SVP RnD of ADC Therapeutics before Genmab + Crucell + Pharming) |
Research & Development Manager |
ADC Therapeutics (Group) |
Switzerland |
| van Blitterswijk, Clemens (Life Sciences Partners 201412 Partner before Founder of Isotis OrthoBiologics) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Netherlands |
| van Camp, Wim (BASF 201310 Managing Director of CropDesign) |
Managing Director |
BASF (Group) |
Belgium |
| van Dam, Barend (EW Group 202004 CEO + Founder of BioChek BV) |
Chief Executive Officer (CEO) |
EW Group (Erich Wesjohann) (Group) |
Netherlands |
| van Dam, Martin (pharm-analyt 201202) |
n. a. |
pharm-analyt Labor GmbH |
Austria |
| van de Griendt, Robbert (Forbion 201810 General Partner + Hear Investor Relations + Impact) |
General Partner (venture partner) |
Forbion (Group) |
Netherlands |
| van de Sande, André (Xendo 201102– CEO before Schering-Plough Netherlands before Organon) |
Chief Executive Officer (CEO) |
Xendo (Group) |
Netherlands |
| van de Sande, Peter (Synaffix 201904 CEO) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Netherlands |
| van de Stolpe, Onno (Galapagos 1999–202203 CEO + Founder before IntroGene BV + Molecular Probes Europe BV RETIRED 4/22) |
Chief Executive Officer (CEO) |
Galapagos (Group) |
Belgium |
| van de Winkel, Jan (Genmab 201106 CEO before CSO + Co-Founder before Medarex Europe) |
Chief Executive Officer (CEO) |
Genmab (Group) |
Denmark |
| Van den Berghe, Jan (Novalis Biotech 202205 Manaing Director + Co-Founder formerly Genohm 201503) |
Managing Director |
Agilent (Group) |
Switzerland |
| Van den Bossche, Jan (Andera Partners 202207– Partner Life Sciences Team before Fund+ + DSM + Petercam) |
Partner (venture partner) |
Andera Partners (FR) |
France |
| Van den Brulle, Jan (Sloning BioTechnology 201004 Scientific Director R&D) |
Research & Development Manager |
MorphoSys (Group) |
Germany |
| van den Dool, Gerrit (SigmaAlrich 199901– Head European Sales) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
United States (USA) |
| van den Hoven, Ton (SurgVision 201710 CEO) |
Chief Executive Officer (CEO) |
Bracco (Group) |
Netherlands |
| van den Oever, Jeroen (Sun Bioscience 202310 CFO) |
Chief Executive Officer (CEO) |
|
Switzerland |
| van der Broek, Lykele (Bayer 201012 COO Bayer CropScience before Bayer Animal Health 200610– division head) |
Chief Operating Officer (COO) |
Bayer (Group) |
Germany |
| Van der Geyten, Serge (JnJ 201501 Director for Neuroscience External Affairs at Janssen Pharmaceutica NV) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
Belgium |
| Van der Heide, Teun (Lonza 201303 Head Lonza Bioscience) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| van der Horst, Robert-Jan (Equinet Bank 201410 Research Analyst) |
Analyst (Financial / Industry) |
Equinet (Group) |
Germany |
| van der Knaap, Rob (Spark Holland 200804– President ) |
President/Director/Head Business Group/Unit/Division |
Spark Holland (Group) |
Netherlands |
| van der Laan, Gerard Paul (MS Vision 202110 Managing Director) |
Managing Director |
MS Vision (Group) |
Netherlands |
| van der Meer, Edward (Healthy Aging Campus Netherlands 201410 Managing Director) |
Cluster Manager |
Healthy Ageing Campus Netherlands |
Netherlands |
| van der Veen, Lars (iOnctura 201706– COO before Solvay Pharma + Organon + Boehringer Ingelheim) |
Chief Operating Officer (COO) |
iOnctura (Group) |
Switzerland |
| van der Velden, Frank-Jan (Xpand Biotechnology 201612 Head Business Affairs + Finance) |
Chief Business Officer (CBO) |
Kuros (Group) |
Netherlands |
| van der Zande, Piet (Thermo Fisher 201006 Managing Director Thermo Fisher Scientific GmbH) |
Managing Director |
Thermo Fisher (Group) |
Germany |
| van Dessel, Vincent (Euronext 201511 CEO of Euronext Brussels) |
Chief Executive Officer (CEO) |
Euronext (Group) |
Belgium |
| van Deventer, Sander (VectorY 202211– CEO + Co-Founder before CTO also Co-Founder of Forbion) |
General Partner (venture partner) |
Forbion (Group) |
Netherlands |
| van Duijnhoven, Henk (Danaher 201409 SVP Dental Segment) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| van Gool, Alain (Univ Nijmegen 201904 Prof + Head of CoE for Translational Omics) |
Professor |
University of Nijmegen (Radboud University) |
Netherlands |
| van Gorp, Jasper (Gilde Investment 201708 Managing Partner at Gilde Healthcare) |
Managing Partner |
Gilde Investment (Group) |
Netherlands |
| van Grieken, Stef (Cradle Bio 202211 CEO + Co-Founder before Google) |
Chief Executive Officer (CEO) |
Cradle Bio B.V. |
Netherlands |
| van Hagen, Paul (Xeltis 201602– CFO before Prosensa + Crucell + Ernst & Young) |
Chief Financial Officer (CFO) |
Xeltis (Group) |
Switzerland |
| van Hall, André (BioCampus Cologne 201307– Prokurist before BioMedizinZentrum Dortmund) |
n. a. |
BioCampus Cologne Management GmbH |
Germany |
| Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G) |
Chief Executive Officer (CEO) |
Argenx (Argen-X) (Group) |
Netherlands |
| Van Heekeren, Robbert (Byondis 202009– CFO before Odyssee Mobile + Kiadis Pharma + Proxy Laboratories + Organon) |
Chief Financial Officer (CFO) |
Byondis (Group) |
Netherlands |
| van Hoeven, Kees (Netherlands (govt) 201405 RVO) |
Administrative Officer (personnel) |
Netherlands (govt) |
Netherlands |
| Van Holen, Roel (Molecubes 202111 CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Belgium |
| van Houten, François Adrianus (Frans) (Philips 201104– designated CEO before since 1986 at Philips) |
Chief Executive Officer (CEO) |
Philips (Group) |
Netherlands |
| van Husen, Georg (Boehringer Ingelheim 201804 SVP Therapeutic Area CardioMetabolism) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| van Koppen, Chris J. (ElexoPharm 201201– Head of Research before Merck Sharp & Dohme NL) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ElexoPharm GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 78 79 80 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
